The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer

References

• Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC cancer staging manual. CA Cancer J Clin 2006;56:37–47.
   PubMed Web of Science ®Google Scholar
• Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E. FDG-PET for axillary lymph node staging in primary breast cancer. Eur J Nucl Med Mol Imaging 2004;31: S97–102.
   Google Scholar
• Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136–8.
   PubMed Web of Science ®Google Scholar
• Shaw JH, Rumball EM. Complications and local recurrence following lymphadenectomy. Br J Surg 1990;77:760–4.
   PubMed Web of Science ®Google Scholar
• Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, . American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703–20.
   PubMed Web of Science ®Google Scholar
• Borqstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275–83.
   Google Scholar
• Chaqpar AB, Martin RC, Scoqqins CR, Carlson DJ, Laidley AL, El-Eid SE, . Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery 2005;138:56–63.
   Google Scholar
• Duchesne N, Jaffey J, Florack P, Duchesne S. Redefining ultrasound appearance criteria of positive axillary lymph nodes. Can Assoc Radiol J 2005;56:289–96.
   PubMed Web of Science ®Google Scholar
• Damera A, Evans AJ, Cornford EJ, Wilson AR, Burrell HC, James JJ, . Diagnosis of axillary nodal metastasis by ultrasound-guided core biopsy in primary operable breast cancer. Br J Cancer 2003;89:1310–13.
   Google Scholar
• Yang WT, Ahuja A, Tang A, Suen M, King W, Metreweli C. High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 1996; 15:241–6.
   PubMed Web of Science ®Google Scholar
• Vaidya JS, Vyas JJ, Thakur MH, Khandelwal KC, Mittra I. Role of ultrasonography to detect axillary node involvement in operable breast cancer. Eur J Surg Oncol 1996; 22:140–3.
   Google Scholar
• Adler LP, Crowe JP, al-Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology 1993;187: 743–50.
   PubMed Web of Science ®Google Scholar
• Utech CI, Young CS, Winter PF. Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunohistochemistry. Eur J Nucl Med 1996; 23:1588–93.
   Google Scholar
• Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, . Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst 1996;88:1204–9.
   Google Scholar
• Khalkhali I, Diqqles LE, Taillefer R, Vandestreek PR, Peller PJ, Abdel-Nabi HH. Procedure guideline for breast scintigraphy. Society of Nuclear Medicine. J Nucl Med 1999;40:1233–5.
   Google Scholar
• Lumachi F, Tregnaghi A, Ferretti G, Povolato M, Marzola MC, Zucchetta P, . Accuracy of ultrasonography and 99mTc-sestamibi scintimammography for assessing axillary lymph node status in breast cancer patients. A prospective study. Eur J Surg Oncol 2006;32:933–6.
   Google Scholar
• Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Hasegawa Y, . Gamma probe and ultrasonographically-guided fine-needle aspiration biopsy of sentinel lymph nodes in breast cancer patients. Eur J Surg Oncol 2001; 27:141–5.
   Google Scholar
• Alvarez S, Añorbe E, Alcorta P, López F, Alonso I, Cortés J. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. Am J Roentgenol 2006;186:1342–8.
   Google Scholar
• Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kröger R, Peterse JL, . Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 2003;39:1068–73.
   PubMed Web of Science ®Google Scholar
• Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Glovanazzi R, . Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst 2001;93:630–5.
   PubMedGoogle Scholar
• Chung A, Liou D, Karlan S, Waxman A, Fujimoto K, Hajiike M, . Preoperative FDG-PET for axillary metastases in patients with breast cancer. Arch Surg 2006;141:783–9.
   Google Scholar
• Gopalan D, Bomanji JB, Costa DC, Ell PJ. Nuclear medicine in primary breast cancer imaging. Clin Radiol 2002;57:565–74.
   Google Scholar
• Avril N, Rosé CA, Schelling M, Dose J, Kuhn W, Bense S, . Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 2000;18:3495–502.
   PubMed Web of Science ®Google Scholar
• Feuardent J, Soret M, de Dreuille O, Foehrenbach H, Buvat I. Reliability of SUV estimates in FDG PET as a function of acquisition and processing protocols. Nuclear Science Symposium Conference Record 2003;4:2877–81.
   Google Scholar
• Beaulieu S, Kinahan P, Tseng J, Dunnwald LK, Schubert EK, Pham P, . SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences. J Nucl Med 2003;44:1044–50.
   PubMed Web of Science ®Google Scholar